retatrutide phase 2 trial obesity triple agonist hormone receptor for metabolic dysfunction-associated steatotic liver disease: a randomized 2a retatrutide triple agonist phase 2
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18






























